Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 3 Nuclear-penetrating autoantibodies and synthetic lethality

Published byTamsyn Booker Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 3 Nuclear-penetrating autoantibodies and synthetic lethality"— Presentation transcript:

1 Figure 3 Nuclear-penetrating autoantibodies and synthetic lethality
Figure 3 | Nuclear-penetrating autoantibodies and synthetic lethality. Nuclear-penetrating autoantibodies can inhibit DNA repair or directly damage DNA. In normal homology-directed repair (HDR)-proficient cells, this DNA damage can be repaired and the cells survive. Cancer cells that are HDR-deficient, however, cannot tolerate the accumulation of DNA double-strand breaks (DSBs) and ultimately die. The combination of these antibodies and HDR deficiency, therefore, leads to synthetic lethality. Noble, P. W. et al. (2016) DNA-damaging autoantibodies and cancer: the lupus butterfly theory Nat. Rev. Rheumatol. doi: /nrrheum

Download ppt "Figure 3 Nuclear-penetrating autoantibodies and synthetic lethality"

Similar presentations

Repairing Damages Bases 1. Mismatch repair (MMR) Dam methylase:MutS:

Repairing Damages Bases 1. Mismatch repair (MMR) Dam methylase:MutS:
BRCA2 Clark Cunningham March 26, 2015 BIOL445 American Cancer Society, eastcancer/make-a-pink-ribbon-lapel-pin,

BRCA2 Clark Cunningham March 26, 2015 BIOL445 American Cancer Society, eastcancer/make-a-pink-ribbon-lapel-pin,
Normal cell cycle DNA replication Doughter cells G2 phase Nuclear division Cytokinesis 1x.

Normal cell cycle DNA replication Doughter cells G2 phase Nuclear division Cytokinesis 1x.
Targeting the DNA Damage Response in Cancer

Targeting the DNA Damage Response in Cancer
Figure 3 The induction of anti-DNA antibodies by bacterial DNA

Figure 3 The induction of anti-DNA antibodies by bacterial DNA
Non-homologous End Joining (NHEJ)

Non-homologous End Joining (NHEJ)
An Introduction to DNA Damage Repair in Cancer: Beyond PARP

An Introduction to DNA Damage Repair in Cancer: Beyond PARP
Figure 1 Role of innate lymphoid cells (ILCs) in steady state,

Figure 1 Role of innate lymphoid cells (ILCs) in steady state,
Figure 2 Cell-mediated disease mechanisms of lupus nephritis

Figure 2 Cell-mediated disease mechanisms of lupus nephritis
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Connexins in cartilage

Figure 3 Connexins in cartilage
Figure 5 Involvement of B cells in SLE

Figure 5 Involvement of B cells in SLE
Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.

Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Factors underlying metabolic alterations in osteoarthritis

Figure 1 Factors underlying metabolic alterations in osteoarthritis
Figure 1 Induction of immune tolerance

Figure 1 Induction of immune tolerance
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 2 Targeted versus untargeted metabolomics approaches

Figure 2 Targeted versus untargeted metabolomics approaches
Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Figure 1 Metabolic profiling as a tool for studying rheumatic diseases
Figure 1 Immune cell metabolism during homeostasis

Figure 1 Immune cell metabolism during homeostasis

Similar presentations

Ads by Google